The NCAA continues to seek ways to have an antitrust trial against the association delayed despite having earlier requests to do so denied. This time, reports say, the NCAA wants the trial put off until February.
The trial, set to begin next month, was filed by onetime collegiate athlete Ed O’Bannon accusing the association of violating antitrust law with its horizontal agreements with member institutions that use the likeness and names of NCAA athletes in products like video games.
But according to NCAA lawyers, plaintiffs “cannot explain how the Court can conduct a meaningful bench trial and be assured that its factual findings will not impinge in any way on a common issue to be presented by the Keller jury.” The Keller jury refers to a lawsuit against the NCAA filed by Sam Keller that challenges the association’s rights-of-publicity. The Keller and O’Bannon cases were combined.
But the NCAA filed a motion Tuesday to have the trial delayed until February because of the cases’ overlap.
In its argument, the NCAA argued that the Seventh Amendment requires legal claims to be tried with a jury before equitable claims if they share a common topic, reports say. The NCAA’s Seventh Amendment did not convince US District Judge Claudia Wilken, however.
Judge Wilken reportedly suggested a bench trial next month with a partial verdict or partial judgment; then, she said, the final decision could be made by a jury trial combined with the Keller case.
Full content: CBS Sports
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Microsoft Moves Closer to Settling EU Antitrust Case Over Teams Integration
May 18, 2025 by
CPI
Meta Moves to Dismiss FTC Antitrust Case Amid Ongoing Trial
May 18, 2025 by
CPI
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas